Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography. (TCI-IRMdiff)
Parkinson's Disease, Impulse Control Disorders
About this trial
This is an interventional diagnostic trial for Parkinson's Disease focused on measuring Parkinson's disease, Impulse control disorders, Diffusion tensor imaging, MRI, Mesocorticolimbic pathway
Eligibility Criteria
Inclusion Criteria:
- Parkinson's disease (UK Parkinson's Disease Society Brain Bank Criteria)
- from 18 to 85 years old
- Impulse control disorder (one item ICD ≥2 at the scale ECMP : Evaluation Comportementale de la maladie de Parkinson)
Exclusion Criteria:
- Dementia (Mini Mental State < 26 or MATTIS < 130)
- Apathy (LARS (Lille Apathy Rating Scale) > 7)
- Depression (MADRS (Montgomery and Alsberg Depression Scale) ≥16
- Contra indication to MRI (claustrophobia, deep brain stimulation, pace maker…)
Sites / Locations
- CHU Clermont-FerrandRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
patients with ICD (impulse control disorder)
patients without ICD (impulse control disorder)
More precisely, the main purpose is to demonstrate that fractional anisotropy (FA) (data obtained with DTI) in the ventral tegmental area (VTA) is different between patients with ICD and patients without ICD
More precisely, the main purpose is to demonstrate that fractional anisotropy (FA) (data obtained with DTI) in the ventral tegmental area (VTA) is different between patients with ICD and patients without ICD